Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yayoi Ando
Observed name:
YAYOI ANDO
Institution:
National Cancer Center Hospital
Observed institution:
National Cancer Center Hospital
ORCID:
0009-0000-0349-0832
Observed ORCID:
0009-0000-0349-0832
OpenAlex ID:
A5103131736
Dabrafenib and trametinib administration in patients with BRAF V600E/R or non-V600 BRAF mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trial
2024
·
Tatsunori Shimoi
, Kuniko Sunami
, et al.
·
EClinicalMedicine
·
45
PDF
Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trial
2023
·
Sae Ishimaru
, Tatsunori Shimoi
, et al.
·
International Journal of Clinical Oncology
·
13
Progress report of a cross‐organ and biomarker‐based basket‐type clinical trial: BELIEVE Trial
2023
·
Yayoi Ando
, Tatsunori Shimoi
, et al.
·
Cancer Science
·
11
PDF
Efficacy of radioactive hypoxia-targeting therapeutic agent 64Cu-ATSM on recurrent malignant glioma: a study protocol for a phase-III, investigator-sponsored, randomized controlled trial
2025
·
Yayoi Ando
, Shunsuke Yanagisawa
, et al.
·
Japanese Journal of Clinical Oncology
·
5
Characterization of a novel comprehensive genomic profiling test with better detection of heterozygous deletions and RNA-based gene fusion analysis
2025
·
Ryouta Kakuta
, Akira Takemoto
, et al.
·
The Oncologist
·
2
PDF
HPV18-positive Small Cell Neuroendocrine Carcinoma of the Uterine Cervix Treated With Immunotherapy: A Case Report
2026
·
SAKIKO MASUMOTO
, MASAAKI TANAKA
, et al.
·
Anticancer Research
·
1
Remarkable Efficacy of Capmatinib in a Patient with Cancer of Unknown Primary with MET Amplification
2025
·
Takaaki Tanaka
, Go Makimoto
, et al.
·
Internal Medicine
·
1
PDF
Barriers to survivorship care for adolescent and young adult cancer survivors: perspectives of survivors and cancer specialists
2026
·
Yuki Kojima
, Yayoi Ando
, et al.
·
Frontiers in Oncology
PDF
Socioeconomic and financial factors associated with financial toxicity in Japanese cancer patients: a cross-sectional study
2026
·
Kazuki Yokoyama
, Kazunori Honda
, et al.
·
Japanese Journal of Clinical Oncology
Phase II trial of trametinib in patients with advanced solid tumors harboring genomic alterations in the MAPK pathway: Results from the BELIEVE trial (NCCH1901).
2025
·
Hideyuki Hayashi
, Junichi Matsubara
, et al.
·
Journal of Clinical Oncology
PDF
A Case of Metastatic Castration-resistant Prostate Cancer with Tumor Mutation Burden-high Presented Remarkable Response to Atezolizumab
2024
·
Atsuhiro Kijima
, Takashi Matsumoto
, et al.
·
Journal of Precision Oncology
Show more works
View as search
Works count:
11
Citation count:
78
H-index:
4
I10-index:
3
Year
Topic
Type